COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine.
COVID-19
cardiovascular medicine
cardiovascular system
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
14 Jun 2021
14 Jun 2021
Historique:
entrez:
15
6
2021
pubmed:
16
6
2021
medline:
17
6
2021
Statut:
epublish
Résumé
A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield symptomatic improvement, ivabradine was commenced. This intervention was followed by a substantial improvement in the patient's exercise tolerance and energy levels and an objective reduction in supine and standing heart rate.
Identifiants
pubmed: 34127505
pii: 14/6/e243585
doi: 10.1136/bcr-2021-243585
pmc: PMC8204164
pii:
doi:
Substances chimiques
Ivabradine
3H48L0LPZQ
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Clin Auton Res. 2020 Dec;30(6):571-573
pubmed: 32970212
Heart Rhythm. 2015 Jun;12(6):e41-63
pubmed: 25980576
Mayo Clin Proc. 2007 Mar;82(3):308-13
pubmed: 17352367
Postgrad Med J. 2007 Jul;83(981):478-80
pubmed: 17621618
Neurology. 1993 Jan;43(1):132-7
pubmed: 8423877
J Intern Med. 2019 Oct;286(4):438-448
pubmed: 30861229
Neurology. 2020 Aug 25;95(8):e1060-e1070
pubmed: 32482845
Can J Neurol Sci. 2005 May;32(2):264
pubmed: 16018168
J Am Coll Cardiol. 2021 Feb 23;77(7):861-871
pubmed: 33602468
Circulation. 2013 Jun 11;127(23):2336-42
pubmed: 23753844